Randomized Pilot Study of a Keratin-based Topical Cream for Radiation Dermatitis in Breast Cancer Patients
Purpose: Radiotherapy (RT) is commonly used in the treatment of breast cancer and often, despite advances in fractionated dosing schedules, produces undesirable skin toxicity. The purpose of this study was to evaluate the feasibility of using a keratin-based topical cream, KeraStat® Cream (KC; KeraN...
Main Authors: | Karen M. Winkfield MD, PhD, Ryan T. Hughes MD, Doris R. Brown MD, PhD, Ryan M. Clohessy PhD, Robert C. Holder PhD, Gregory B. Russell MS, Alexis F. Rejeski MBA, Luke R. Burnett PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-01-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338231222137 |
Similar Items
-
Treatment of cutaneous lupus with topical ruxolitinib cream
by: Jonathan J. Park, PhD, et al.
Published: (2022-10-01) -
Review of the Terminology Describing Ionizing Radiation-Induced Skin Injury: A Case for Standardization
by: Luke R. Burnett PhD, et al.
Published: (2021-10-01) -
Human papillomavirus–related condyloma on keratinized skinKey message
by: Gyohei Egawa, MD, PhD, et al.
Published: (2022-10-01) -
The ability of biomarkers to assess the severity of atopic dermatitis
by: Takeshi Nakahara, MD, PhD, et al.
Published: (2024-02-01) -
A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysisCapsule Summary
by: Norito Katoh, MD, PhD, et al.
Published: (2022-03-01)